XTSX
LOVE
Market cap142mUSD
, Last price
CAD
Name
Cannara Biotech Inc
Chart & performance
P/E
—
P/S
—
EPS
0.13
Vol. 1Y
—
Shs. 5Y
5.30%
Rev. 5Y
111.25%
Div Yld LY
—
Div Yld TTM
—
Revenues
107m
+31.28%
Net income
13m
+103.09%
CFO
20m
+87.34%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities. Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.
Key people
Nicholas Sosiak
Chief Financial Officer · since 2024
Avi Krivorot
Chief Technology Officer · since 2021
Noemi Follain
Vice President - Finance · since 2023
Anthony Manouk
Vice President - Compliance, General Manager · since 2023
Lead Independent Director · since 2024
Mary Durocher
Director · since 2024
Zohar Krivorot
Chairman of the Board, Chief Executive Officer · since 2022
Derek Stern
Director · since 2022
Justin Cohen
Independent Director · since 2025
Headquarters & legal address
1055 West Georgia St.
Vancouver, BC V6E 4N7
CA
Vancouver, BC V6E 4N7
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑08 | 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||